ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 189 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,667,200 | -79.2% | 80,000 | -51.5% | 0.55% | -74.0% |
Q2 2020 | $7,998,000 | -60.1% | 165,000 | -78.0% | 2.11% | -49.3% |
Q2 2019 | $20,048,000 | -17.0% | 750,000 | -16.7% | 4.16% | -34.1% |
Q1 2019 | $24,165,000 | +1095.7% | 900,000 | +620.0% | 6.31% | +761.3% |
Q4 2018 | $2,021,000 | -90.3% | 125,000 | -87.5% | 0.73% | -83.4% |
Q3 2018 | $20,760,000 | +154.1% | 1,000,000 | +86.9% | 4.41% | +83.5% |
Q2 2018 | $8,169,000 | -9.1% | 535,000 | +33.8% | 2.40% | +32.2% |
Q1 2018 | $8,988,000 | +118.9% | 400,000 | +267.0% | 1.82% | +108.5% |
Q3 2017 | $4,106,000 | -46.5% | 109,000 | -60.4% | 0.87% | -45.3% |
Q2 2017 | $7,670,000 | -60.0% | 275,000 | -50.6% | 1.59% | -55.4% |
Q1 2017 | $19,157,000 | +47.6% | 557,200 | +23.8% | 3.57% | +14.3% |
Q4 2016 | $12,978,000 | +104.0% | 450,000 | +125.0% | 3.12% | +202.6% |
Q3 2016 | $6,362,000 | -46.5% | 200,000 | -52.9% | 1.03% | -84.7% |
Q1 2016 | $11,883,000 | +33.3% | 425,000 | +70.0% | 6.72% | +84.3% |
Q4 2015 | $8,913,000 | +127.9% | 250,000 | +108.3% | 3.65% | +419.1% |
Q1 2015 | $3,911,000 | – | 120,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |